Associate Director of HCP Promotional Marketing

Location: Princeton, NJ ONSITE

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

• HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
• HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
• HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

• HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

The Associate Director of HCP Promotional Marketing will support the implementation and execution of brand strategy and core messaging for our NSCLC indications, helping to bring a clear, compelling brand narrative to life for HCPs. In this role, you will play a key part in translating strategy into effective field-facing and scientific engagement experiences.

Reporting to the Director of HCP Promotional Marketing, you will partner closely with cross-functional teams to ensure consistent pull through of messaging across channels and touchpoints. This role offers the opportunity to serve as a strong operational leader, contributing to high quality execution while building influence and expertise within a dynamic, launch focused organization.

Role and Responsibilities:

• Lead execution of the HCP brand strategy and core messaging for NSCLC indications, ensuring strong pull-through with the US field sales team and across key promotional touchpoints
• Serve as the marketing partner for the field, translating brand strategy and complex scientific concepts into clear, actionable execution guidance to drive effective HCP engagement
• Support the development, review, and approval of compliant derivative promotional materials that extend core brand messaging across channels
• Support planning and execution of promotional congress and major meeting activities
• Partner closely with Sales Leadership and Field Learning & Development to support field meetings, training material, and ongoing field enablement initiatives
• Monitor field feedback, marketplace insights, and competitive dynamics to inform ongoing optimization of messaging and execution

• Translate clinical data and strategic direction into compelling, compliant derivative promotional materials

• Support refinement of messaging based on evolving data, competitive landscape, and field insights